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Prevalence and Distribution of Coronary Disease in Claudicants Using
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T. N. Sonecha and K. T. Delis
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Aims: to evaluate the prevalence of coronary artery disease (CAD) by means of modified stress electrocardiography in
patients presenting with intermittent claudication.
Methods: three hundred consecutive patients (188 male) with intermittent claudication (post-exercise ankle brachial index
50.8), and 100 age and sex-matched controls, were assessed for CAD with resting and stress 12-lead-precordial ECG. A
history of angina and previous myocardial infarction (MI) was recorded. Exclusion criteria: recent (51 month) MI;
unstable angina; prior coronary intervention; arrhythmias; conduction abnormalities; uncontrolled hypertension; heart
failure, digoxin therapy, and inability to perform tests.
Results: based on antecedent angina, MI and abnormal resting ECG, CAD prevalence was 47% in claudicants and 6% in
controls; on 12-lead-precordial ECG stress testing, CAD prevalence was 46% (95% CI: 40.1±51.7%) in claudicants and
11% (95% CI: 4.8±17.2%) in controls (both p5 0.0001). Only 67% of claudicants (n 141) with antecedent angina, MI
or an abnormal resting ECG, met the criteria of CAD on stress testing; also 28% of claudicants without antecedent angina,
MI and a normal resting ECG (n 159) had evidence of CAD. The odds ratio for CAD in claudicants was 6.9. Based on
12-lead-precordial ECG stress testing we detected the presence of: one-, two- and three-vessel disease in 14.7% (95% CI:
10.6±18.7%), 19% (95% CI: 14.5±23.5%) and in 12.3% (95% CI: 8.6±16%) of claudicants; and in 8, 3 and 0% of controls,
respectively.
Conclusions: forty six percent of patients with intermittent claudication had concomitant CAD, and 31% two- or three-
vessel disease. In the presence of claudication the odds ratio for CAD is 6.9 (95% CI: 3.5±13.4) and for two- or three-vessel
disease 14.8. Non-invasive modified stress electrocardiography by enabling identification of those with multi-vessel CAD
and thus by providing cardiac risk stratification may help bridge the gap between clinical evaluation and invasive coronary
imaging.
Key Words: CAD; MI; ECG; 12-lead precordial ECG; Claudication; PVD/PAOD.
Introduction
Whilst patients with atherosclerotic disease may pre-
sent with symptoms pertaining to a single territory,
other arterial segments may also be affected by con-
comitant occult disease.1,2 It has been reported that
coronary artery disease (CAD) is present in over 50%
of patients with clinically detectable peripheral arterial
occlusive disease (PAOD).3 Yet, in over 60% CAD may
remain asymptomatic.4 The onset of intermittent clau-
dication may present a window of opportunity to
detect occult concurrent CAD.5 Although intermittent
claudication is a fairly benign clinical entity with 75%
of patients being stabilized or improved with time
without intervention and only 5% requiring surgical
or percutaneous intervention in 5 years,4 it is
associated with a significantly reduced survival.1,6
Thirty percent of patients presenting to their physician
with intermittent claudication will not be alive in 5
years either due to cardiac (53%), cerebrovascular
(23%) or non-vascular events (23%), with mortality
exceeding 50% at 10 years.4
Only 18% of patients with PAOD have normal cor-
onary arteries on angiography.5 As up to 50% of
patients sustaining an acute myocardial infarction
(MI) have no antecedent or prodromal symptoms,6
and cardiac mortality in patients with PVD improves
with aorto-coronary bypass surgery,7 identification of
those with clinically relevant CAD merits prime con-
sideration. Although angiography remains the gold
standard for detection of CAD, its routine application
in patients presenting with intermittent claudication
would overwhelm already stretched cardiac services
both logistically and financially. The expanding role
of non-invasive methods warrants their application
for the detection of CAD enabling optimal use of
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angiography. Conventional dynamic ECG stress test-
ing with its conceptual simplicity is widely accepted as
a tool to detect ischaemic heart disease. However, it fails
to offer insightful information on the extent of afflicted
coronary arteries. Further to its ability to detect myo-
cardial ischaemia, stress testing using 12-lead-precor-
dial ECG is able to identify the coronary territories
manifesting ischaemia and by inference the coronary
arteries with significant disease.8,9 The aim of this cross-
sectional controlled study was to evaluate the preva-
lence of CAD in patients presenting with intermittent
claudication in relation to its distribution and severity
in terms of ischaemic territories, using the non-invasive
method of modified stress electrocardiography.
Study Design
This is a cross-sectional controlled study performed in
a university-affiliated tertiary care hospital consisting
of consecutive subjects with arterial intermittent clau-
dication recruited prospectively.
Materials and Methods
Three hundred consecutive patients with intermittent
claudication prospectively recruited from a catchment
area of 700 000 population in the North±West Thames
region of London, had their cardiac function evalu-
ated for the presence of CAD using resting and stress
electrocardiography. All had clinical evidence of
PAOD detected by the absence of peripheral pulses,
the presence of peripheral bruits and abnormal ankle-
brachial pressure indices at rest (50.8) decreasing
further after a standard 1-min (4 km/h; 10% inclina-
tion) treadmill exercise. They also had typical inter-
mittent claudication reproducible on lower limb
arterial treadmill exercise. History of angina pectoris
(exertion-induced chest pain or tightness or discom-
fort) and previous MI was recorded.
Excluded were patients with: a recent (51 month) MI;
unstable angina; previous percutaneous intervention or
coronary artery bypass grafting; arrhythmias including
atrial fibrillation, previous ventricular tachycardia, ven-
tricular fibrillation or cardiac arrest; frequent ventricular
premature beats (410 per min), heart failure, pace-
maker implantation; conduction abnormalities includ-
ing left-bundle branch, bi-fascicular or complete
right-bundle branch blocks; uncontrolled systemic
hypertension; left- or right-ventricular hypertrophy,
inability to perform treadmill exercise and bicycle ergo-
metry, and those on digoxin therapy.
The control group consisted of 100 individuals
without intermittent claudication, matching the
group of claudicants for age and sex. They repre-
sented the same catchment area as the recruited arter-
iopaths, subject to a similar referral pattern; had been
referred for assessment of suspected PAOD, but on
examination they had a full complement of infra-
and supra-aortic pulses, no evidence of bruits and
normal ankle brachial pressure indices both at rest
and after treadmill exercise (1.0). Like those with
claudication, the control individuals also had their
cardiac function evaluated for the presence of CAD
using resting and 12-lead-precordial stress testing.
The demography of the investigated populations is
depicted in Table 1.
Investigation protocol
The protocol implemented in the investigation of the
group of claudicants and the controls is schematically
presented in Figure 1.
Table 1. Demography, PAOD and walking ability parameters of the claudicants, control subjects and patients
included in the validation study.
Claudicants Control subjects Validation study patients
Age 62.3 (44±81) 61.2 (41±77) 66.4 (53±76)
Gender (M/F) 188/112 64/36 51/19
Diabetes Mellitus 41 (13.7%) 8 (8%) 10 (14.2%)
Hypertension 78 (26%) 19 (19%) 22 (31.4%)
Smoking 62 (20.7%)  11 (11%)  16 (22.8%)
Hyperlipidaemia 51 (17%) 14 (14%) 13 (18.6%)
Resting ABPI 0.58 (0.38±0.8) 41.0 0.52 (0.32±0.76)
Post-exercise ABPI 0.27 (0.23±0.74) 41.0 0.23 (0.19±0.71)
Initial claudication distance 97 m (20±289) ± 65 m (22±148)
Absolute claudication distance 174 m (35±782)  ± ±
For inclusion and exclusion criteria please refer to material and methods. Hyperlipidaemia was defined as serum total
cholesterol exceeding 5.0 mmol/l or serum triglycerides greater than 2.0 mmol/l, or both. Post-exercise ABPIs measured
within a minute of termination of exercise challenge at 4.0 km/h, 10%, 1 min Claudication determined on treadmill
exercise (4.0 km/h, 10%). Differences in age and gender between claudicants and controls were non significant.Proportion of smokers amongst claudicants significantly higher than control group (p5 0.05).
** Over 30% of claudicants failed to complete protocol for absolute claudication distance.
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Clinical assessment with emphasis on CAD and PVD  
Resting period of 15 min
Conventional resting ECG 
12-lead precordial ECG stress testing 
Resting period of 15 min
Resting and post treadmill exercise (1min; 4 km/h; 10%) ankle brachial pressure indices  
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(b) Previous infarction: Q wave: duration 40 ms or
amplitude 25% of R wave.
Criteria for a positive 12-lead-precordial ECG
stress testing
(a) Horizontal or downsloping exercise-induced ST
depression 1 mm below the isoelectric, 80 ms
after the J point in three consecutive beats on a
stable baseline, compared with resting ECG.
(b) Q wave duration 40 ms, or amplitude 25% of R
wave or both.
Criteria for a negative 12-lead-precordial ECG
stress testing
Absence of criteria (a) and (b) with 85% of target
(220-age in years for males, 210-age for females) heart
rate attained.
Criteria for an inconclusive 12-lead-precordial
ECG stress testing
Absence of criteria (a) and (b) with 585% of target
(220-age in years for males, 210-age for females) heart
rate achieved.
Statistics
Differences in proportions in the evaluated cohorts
were statistically assessed using the 2 test with a Yate's
correction when required. Quantitative data between
two groups were compared using the Mann±Whitney
U test. Odds ratio and 95% confidence intervals (95%
CI) are provided in support of the prevalence and
odds ratio. Assessment of 12-lead-
precordial ECG stress testing for detection and quan-
tification of CAD in relation to coronary angiography
was performed by calculation of the positive predic-
tive value (PPV) in addition to sensitivity, specificity
and negative predictive value (NPV).
Results
CAD prevalence based on the presence of (i) a history
of angina pectoris, (ii) MI or (iii) an abnormal resting
ECG was 47% [141/300] in the group of claudicants and
6% [6/100] in the control subjects (p5 0.0001); on 12-
lead-precordial ECG stress testing, CAD prevalence
was 46% [138/300] (95% CI: 40.1±51.7%) and 11% [11/
100] (95% CI: 4.8±17.2%), respectively (p5 0.0001).
Twenty six percent [79/300] (95% CI: 21.3±31.4%) of
claudicants and 74% [74/100] (95% CI: 65.3±82.8%) of
the control group had a normal ECG stress testing.
Inconclusive data on 12-lead-precordial ECG stress
testing was obtained in 28% [83/300] of claudicants
and 15% [15/100] of the control population.
Of the claudicants (n 141) with suspected CAD
based on history of angina and MI or an abnormal
resting ECG, only 67% [93/141] manifested myocar-
dial ischaemia on 12-lead-precordial ECG stress test-
ing; 12.8% [18/141] had no evidence of ischaemia and
21.3% [30/141] an inconclusive test.
Of those not suspected as having CAD, based on
antecedent angina, MI or an abnormal resting ECG
(n 159), the presence of ischaemia was documented
in 28% [45/159] using 12-lead-precordial ECG stress
testing; the test was inconclusive in 33.3% [53/159],
and normal only in 38.4% [61/159].
The odds ratio of myocardial ischaemia on 12-lead-
precordial ECG stress testing amongst the patients with
intermittent claudication was 6.9 (95% CI: 3.5±13.4).
Based on the extent of myocardial ischaemia or
presence of Q waves in relation to the cardiac
territories perfused by the coronary arteries on 12-
lead-precordial ECG stress testing we detected the
presence of: single vessel territory disease in 14.7%
(95% CI: 6.4±18.7%) [44/300] claudicants, and 8%
(95% CI: 2.6±13.4%) [8/100] control subjects
(p4 0.05); two vessel territory disease in 19% (95%
CI: 14.5±31.4%) [57/300] claudicants and 3% (95% CI:
0±6.4%) control subjects (p5 0.001), and three vessel
territory disease in 12.3% (95% CI: 0.6±16.1%) [37/300]
claudicants and none (0%) in control subjects
(p5 0.001). The distribution of CAD territories as
indicated by 12-lead precordial ECG stress test in 300
patients with intermittent claudication, and 100 con-
trol subjects is depicted in Table 2.
Depicted in Table 3 is stratification of the results of
12-lead-precordial ECG stress testing based on the
detection of myocardial ischaemia in relation to heart
rate attained and expressed as percentage of the target
heart rate amongst 300 patients with intermittent clau-
dication. When compared with coronary angiography,
the PPV of 12-lead-precordial stress testing in identify-
ing 450% luminal diameter stenosis in patients with
intermittent claudication was 91% for lesions of the
left anterior descending artery, 85% for circumflex and
91% for right coronary. The overall performance of
12-lead-precordial stress testing is depicted in Table 4.
Discussion
The present study has shown that the prevalence of
CAD in patients with arterial claudication based on
antecedent angina pectoris, MI or an abnormal resting
ECG is 47%, over seven times higher than in indivi-
duals without PAOD. This is in keeping with previous
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studies reporting 40±60% of CAD in subjects with
lower extremity ischaemia4,5,10±12 and 5±14% of CAD
in those without.13,14 On optimal exercise chal-
lenge,15,16 46% of our claudicants developed ECG
signs of reversible myocardial ischaemia, over four
times as many as non-claudicants. These findings
lend support to the clinical notion that intermittent
claudication is a marker of generalized atherosclerosis
involving the coronary arteries.1,5,10,11,17±19 Clinical
outcome in patients with claudication, despite the
benign course of PAOD progressing to critical limb
ischaemia in less than 5% in five years,4 is oversha-
dowed by a greatly reduced survival,7,20 similar to
that after resection of a Duke's B carcinoma of the
colon.4 By comparison, matched non-claudicant con-
trol individuals have a survival rate of 90% at 5 years,
over 80% at 10 years and over 70% at 15 years.4 This
discrepancy in survival becomes critical in view of the
high incidence and prevalence of intermittent claudi-
cation in Western societies21,22 affecting 4.5±9% of the
population over 55 years,21,23 the weighted mean
incidence estimated at 5±10 per 1000 population per
annum.24,25 As cardiac events account for over 50% of
deaths amongst claudicants without coronary inter-
vention,26,27 and CAD may remain asymptomatic as
a result of exercise impairment by claudication,28,29
early detection of CAD and occult myocardial ischae-
mia becomes imperative.5,7,28,30
ECG stress testing demonstrated evidence of CAD
in almost as many as those clinically suspected based
on antecedent angina, MI or an abnormal resting ECG.
Despite numerical parity, ECG stress testing was able
to detect CAD amongst those clinically unsuspected,
and conversely exclude myocardial ischaemia in the
presence of cardiac history. An additional 45/300
patients (15%) with myocardial ischaemia were iden-
tified amongst those clinically unsuspected (141/300),
with no antecedent symptoms or current ECG signs,
on ECG stress testing; further, 18/141 patients (13%)
amongst those clinically suspected as having CAD did
not develop myocardial ischaemia, whereas 30/141
(21%) had an inconclusive result. Amongst the control
subjects, ECG stress testing identified 11/100 with
CAD in total as compared with 6/100 suspected as
having CAD on clinical grounds. Finally, only 38%
(61/159) of the clinically unsuspected claudicants
completed the stress testing unremarkably, in com-
parison with 79% (74/94) of the control subjects. This
data reiterates the discriminating ability of stress test-
ing to identify not only clinically relevant CAD, but
also compensated CAD featuring no change in ST
morphology on exercise, thus obviating the need for
further cardiac investigation in the latter.
Further to its ability to detect the presence of myo-
cardial ischaemia in the investigation of CAD, ECG
stress testing provided incremental information
regarding the distribution of CAD based on the
coronary territories manifesting inducible ischaemia.
Previous work8,9 has established the clinical value of
16-lead-precordial ECG stress testing in the evaluation
of patients with angina and has determined its valid-
ity in relation to coronary angiography. The technique
does not differ from conventional exercise ECG testing
using either orthogonal or single chest (V5) leads in
Table 3. Stratification of the results of 12-lead-precordial ECG
stress testing based on the detection of myocardial ischaemia in
relation to heart rate attained and expressed as percentage
of the target heart rate amongst 300 patients with intermittent
claudication.
Patients (%) % target
heart rate
Myocardial
ischaemia
Result
96 (32) 485 Yes Positive
42 (14) 585 Yes Positive
79 (26.3) 485 No Negative
83 (27.7) 585 No Inconclusive
Table 2. Distribution of CAD in patients with (Claudicants) and without (Controls) intermittent claudication
detected with 12-lead-precordial ECG stress testing.
Claudicants (%) Controls (%) p-value Odds ratio 95% CI
1-vessel CAD 44 (14.7) 8 (8) 40.05 1.98 0.89±4.3
LAD 35 (11.7) 6 (6) 40.05 2.44 0.99±6.0
Cx 5 (1.7) 0 40.2 ± ±
RCA 4 (1.3) 2 (2) 40.2 1.5 0.27±8.3
2-vessel CAD 57 (19) 3 (3) 50.001 7.58 2.3±24.8
LAD/Cx 27 (9.0) 1 (1) 50.02 9.79 1.3±72.9
LAD/RCA 23 (7.7) 2 (2) 40.05 4.07 0.94±17.6
RCA/Cx 7 (2.3) 0 40.2 ± ±
3-vessel CAD 37 (12.3) 0 50.001 ± ±
2 or 3 vessel CAD 94 (31.3) 3 (3) 50.001 14.75 4.6±47.7
Total CAD 138 (46) 11 (11) 50.001 6.89 3.5±13.4
Inconclusive 83 (27.7) 15 (15) 50.02
Negative 79 (26.3) 74 (74) 50.001
Total 300 100
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terms of specificity, but it confers greater sensitivity
(95%) than both.8 Compared with coronary angiog-
raphy, 16-lead-precordial ECG stress testing has
been reported to detect a greater than 50% coronary
artery stenosis with a sensitivity of 98% and specificity
of 88% in patients presenting with chest pain suggest-
ive of angina.9 The method offers validated identifica-
tion of CAD by quantification of the ischaemic
territories of myocardium projected onto the front
and left sides of chest on controlled exercise challenge,
yielding a sensitivity and specificity of 87 and 85% for
the left anterior descending and diagonal arteries
respectively; 71 and 85% for the right coronary artery
(RCA), and 85 and 80% for the circumflex coronary
artery (CX), in comparison with angiography.9 Fox
et al.8 in a further validation found 16-lead-precordial
ECG stress test as having a 95% sensitivity and 92%
specificity for detection of 70% or greater diameter
stenosis compared with coronary angiography. In an
attempt to simplify its application, a modification of
this technique from 16- to 12-precordial-leads was
prompted by the relative lack of incremental informa-
tion offered by the upper horizontal level of electro-
des, placed just beneath the sterno-clavicular joints.9
As shown by our validation (Table 4), this simplifica-
tion has not deprived the technique of its clinical
value. The rationale in the quantification of coronary
arteries harbouring significant occlusive disease
depends on the spatial allocation of (i) the right para-
sternal vertical row of electrodes enabling optimal
evaluation of the RCA territory; (ii) left parasternal
and anterior axillary rows of electrodes interrogating
the left anterior descending coronary artery (LAD)
and its diagonal branch territories, and (iii) the vertical
row 6 cm medial to the posterior axillary line reflect-
ing the circumflex artery territory. In comparison with
conventional ECG stress test yielding information
from six electrodes placed almost uni-planarly, 12-
lead-precordial ECG stress testing yields information
from each individual myocardial region interrogated
by three different electrodes placed across the vertical
span of the heart.
In our series, of the claudicants with CAD: 32%
had evidence of single vessel disease on ECG stress
testing, predominantly (80%) in the anatomic distribu-
tion of the left anterior descending artery; 41% evi-
dence of two-vessel disease, involving the left anterior
descending and RCA territories almost as often as
those of left anterior descending and circumflex
arteries; the remaining 27% had evidence of CAD
affecting all three vessels, left anterior descending,
circumflex and right coronary arteries. In terms of
CAD distribution and prevalence, our findings in
patients with claudication are in agreement with
those obtained both by angiography and other screen-
ing methods. Hertzer et al.5 in a series of 1000 patients
with PAOD for elective peripheral reconstruction who
underwent coronary angiography identified single-
vessel disease in 21%, two-vessel in 20% and triple-
vessel disease in 18%. Based on routine coronary angi-
ography performed in 100 patients undergoing aortic
reconstruction, Tomatis et al.17 reported one- and
three-vessel disease in 28 and 16% of patients with
asymptomatic CAD, respectively. Evaluating the pres-
ence and severity of CAD in 58 PAOD patients with
coronary angiography, Youngman et al.31 diagnosed
CAD (450% stenosis) in 59%, excluding those with
previous cardiac surgery or significant valvular dis-
ease. By comparison the predictive accuracy of clinical
evaluation was 36%, treadmill stress testing 57%, exer-
cise radionuclide ventriculography 57% and non-
invasive diagnostic algorithm 89%. Of their patients
with PAOD 14% had one-vessel disease, 17% two-
vessel and 22% three-vessel disease.
Stress testing conducted in patients with angina
using 16-lead-precordial ECG8 showed single-vessel
disease in 20%, two-vessel in 29% and three-vessel in
36%. These findings in terms of number of coronary
vessels affected are comparable to those in patients
with claudication as detected in our series. It was
surprising to find that the distribution of CAD in
terms of specific vessels involved shared similarity
between the two patient populations (angina vs clau-
dication) on multi-lead precordial ECG stress testing,
the LAD being the most frequently affected territory
irrespective of number of diseased vessels. Whereas
the RCA was the second most frequently detected
diseased territory amongst those presenting with
Table 4. Performance of 12-lead-precordial ECG stress testing for identification of CAD (450% diameter stenosis) in
70 patients with intermittent claudication due to PAOD, in comparison with coronary angiography; actual patient
numbers are stated in brackets.
Sensitivity % Specificity % PPV % NPV %
LAD 98.4 (63/64) ± 91 (63/69) ±
Cx 85.7 (48/56) 35.7 (5/14) 85 (48/57) 38.5 (5/13)
RCA 68.4 (39/57) 69.2 (9/13) 91 (39/43) 33.3 (9/27)
2 and 3 vessel CAD 90.5 (57/63) 14.3 (1/7) 90.5 (57/63) 14.3 (1/7)
3 vessel CAD 68.9 (31/45) 80 (20/25) 86.1 (31/36) 58.8 (20/34)
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angina, circumflex appeared to be more commonly
involved in claudicants.
None of the non-claudicant control individuals in
our series did have three-vessel disease, 3/100 had
two-vessel disease, and 8/100 single-vessel coronary
disease. Further to a 7-fold odds ratio for concomitant
CAD, intermittent claudication was associated with a
15-fold odds ratio for having two- to three-vessel
CAD. In view of the stringent exclusion criteria
applied, resulting in elimination of 10±15% of patients,
our findings perhaps reflect an underestimate of
actual CAD.
The implications of this study are relevant to clinical
decision making in an environment of increasing
awareness for cost containment. 12-lead-precordial
ECG stress testing, estimated at $100, can detect the
presence and distribution of CAD, thus enabling risk
stratification. Offering dynamic cardiac assessment at
a substantially lower cost than stress echocardio-
graphy or perfusion imaging, with the benefit of sim-
plicity, 12-lead-precordial ECG stress testing appears
to meet the requirements of a comprehensive quanti-
tative study in a population with a high prevalence of
concomitant CAD. Pharmacologic stress testing
should be considered for those unable to exercise or
limited to a suboptimal effort, resulting in an incon-
clusive result.
In conclusion, 47% of patients with intermittent
claudication had co-existent CAD on ECG stress test-
ing, which in two-thirds was due to two- or three-
vessel disease. The odds ratio for CAD was 7-fold in
the presence of intermittent claudication and that of
two- or three-vessel disease 15-fold in comparison to
matched controls. Enabling noninvasive dynamic
cardiac assessment with determination of CAD distri-
bution at a low cost, 12-lead-precordial ECG stress
testing allows risk stratification in patients with inter-
mittent claudication, thus helping to bridge the gap
between clinical evaluation and invasive imaging
such as angiography.
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